Creative Planning - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$214,217
-68.2%
25,624
-5.4%
0.00%
-100.0%
Q2 2023$673,114
+73.5%
27,098
+5.0%
0.00%0.0%
Q1 2023$388,047
+32.1%
25,801
+3.9%
0.00%
Q4 2022$293,739
+98.5%
24,830
-0.9%
0.00%
Q3 2022$148,000
+39.6%
25,048
+0.7%
0.00%
Q2 2022$106,000
-93.1%
24,881
-69.3%
0.00%
-100.0%
Q4 2021$1,538,000
+76.2%
80,956
+208.5%
0.00%0.0%
Q3 2021$873,000
+11.8%
26,240
+30.4%
0.00%
+100.0%
Q2 2021$781,000
+43.3%
20,130
+78.1%
0.00%0.0%
Q1 2021$545,000
+10.8%
11,301
+19.6%
0.00%0.0%
Q4 2020$492,000
+228.0%
9,451
-10.5%
0.00%0.0%
Q1 2018$150,000
+275.0%
10,561
+164.0%
0.00%
Q2 2017$40,000
-89.3%
4,000
-87.5%
0.00%
-100.0%
Q1 2017$373,000
+159.0%
32,001
+3.2%
0.00%
+100.0%
Q4 2016$144,000
-38.2%
31,001
+3.0%
0.00%0.0%
Q3 2016$233,000
+19.5%
30,100
-6.4%
0.00%0.0%
Q2 2016$195,000
-28.8%
32,1470.0%0.00%
-50.0%
Q1 2016$274,000
-38.7%
32,147
-14.2%
0.00%
-50.0%
Q4 2015$447,000
+29.6%
37,448
+9.3%
0.00%
+33.3%
Q3 2015$345,000
-37.8%
34,248
+2.4%
0.00%
-40.0%
Q2 2015$555,000
+40.9%
33,448
+31.4%
0.01%
+25.0%
Q1 2015$394,000
+0.3%
25,448
+2.6%
0.00%0.0%
Q4 2014$393,000
+148.7%
24,800
+67.6%
0.00%
+100.0%
Q3 2014$158,00014,8000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders